Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans.

MICs of clarithromycin and its major human metabolite, 14-hydroxy-clarithromycin, for Haemophilus influenzae in combination were reduced two- to fourfold compared with the MICs of each compound alone. Serum reduced the MICs of the parent compound and metabolite two- to fourfold compared with the MIC...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Hardy, D J, Swanson, R N, Rode, R A, Marsh, K, Shipkowitz, N L, Clement, J J
פורמט: Artigo
שפה:Inglês
יצא לאור: 1990
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC175991/
https://ncbi.nlm.nih.gov/pubmed/2143642
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים